Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
Natalia G. Vallianou, Dimitrios Tsilingiris, Gerasimos Socrates Christodoulatos, et al.
Metabolism Open (2021) Vol. 10, pp. 100096-100096
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Herbal medicine use for the management of COVID-19: A review article
Chilot Abiyu Demeke, Alem Endashaw Woldeyohanins, Zemene Demelash Kifle
Metabolism Open (2021) Vol. 12, pp. 100141-100141
Open Access | Times Cited: 98
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 65
Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
Metabolism Open (2021) Vol. 11, pp. 100101-100101
Open Access | Times Cited: 53
COVID-19 vaccines: Current evidence and considerations
Alireza Tavilani, Ebrahim Abbasi Oshaghi, Farhad Kian Ara, et al.
Metabolism Open (2021) Vol. 12, pp. 100124-100124
Open Access | Times Cited: 53
Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
Metabolism Open (2021) Vol. 13, pp. 100159-100159
Open Access | Times Cited: 44
A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids
Chengwen Zheng, Panthakarn Rangsinth, Polly Ho-Ting Shiu, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1756-1756
Open Access | Times Cited: 16
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus
Mackingsley Kushan Dassanayake, Teng-Jin Khoo, Chien Hwa Chong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11131-11131
Open Access | Times Cited: 23
Older adults' acceptance of the COVID‐19 vaccine: Application of the health belief model
Fatma M. Ibrahim, Doaa El Sayed Fadila, Doaa Abd Elmawla
Nursing Open (2023) Vol. 10, Iss. 10, pp. 6989-7002
Open Access | Times Cited: 12
Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study
Sraa Abu‐Melha, Mastoura M. Edrees, Musa A. Said, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 488-488
Open Access | Times Cited: 19
Promising clinical outcomes of nano‐curcumin treatment as an adjunct therapy in hospitalized COVID‐19 patients: A randomized, double‐blinded, placebo‐controlled trial
Majid Sadeghizadeh, Elahe Asadollahi, Babak Jahangiri, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3631-3644
Closed Access | Times Cited: 11
Saffron for “toning down” COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence
Alexios‐Fotios A. Mentis, Μaria Dalamaga, Cuncun Lu, et al.
Metabolism Open (2021) Vol. 11, pp. 100111-100111
Open Access | Times Cited: 24
Clinical metabolomics: useful insights, perspectives and challenges
Μaria Dalamaga
Metabolism Open (2024) Vol. 22, pp. 100290-100290
Open Access | Times Cited: 2
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges
Μaria Dalamaga, Christina Tsigalou
Metabolism Open (2024) Vol. 23, pp. 100310-100310
Open Access | Times Cited: 2
SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
Dimitrios Tsilingiris, Μaria Dalamaga, Junli Liu
Metabolism Open (2022) Vol. 13, pp. 100163-100163
Open Access | Times Cited: 13
The Role of Interferons in Long Covid Infection
Mohammad Karbalaeimahdi, Safar Farajnia, Nasrin Bargahi, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 2, pp. 65-76
Closed Access | Times Cited: 6
The effect of COVID-19 pandemic on the attendance and clinical outcomes of patients with ophthalmic disease: A mini-review
Maria Syriga, Ιrene Karampela, Μaria Dalamaga, et al.
Metabolism Open (2021) Vol. 12, pp. 100131-100131
Open Access | Times Cited: 13
Assessing nanobody interaction with SARS-CoV-2 Nsp9
Gennaro Esposito, Yamanappa Hunashal, Mathias Percipalle, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303839-e0303839
Open Access | Times Cited: 1
Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges
Dimitrios Tsilingiris, Narjes Nasiri‐Ansari, Nikolaos Spyrou, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2494-2494
Open Access | Times Cited: 8
Treatment of severe COVID-19: an evolving paradigm
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 17, pp. 1887-1891
Closed Access | Times Cited: 6
Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals
Patricia de León, Rodrigo Cañas‐Arranz, María José Bustos, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 4
Open Access | Times Cited: 3
Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine
Ebrahim Abbasi Oshaghi, Fatemeh Mirzaei, Heidar Tavilani, et al.
Metabolism Open (2021) Vol. 11, pp. 100122-100122
Open Access | Times Cited: 8
Perspectives and Challenges of COVID-19 with Obesity-Related Cancers
Μaria Dalamaga, Narjes Nasiri‐Ansari, Nikolaos Spyrou
Cancers (2023) Vol. 15, Iss. 6, pp. 1771-1771
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top